Avalere (page inactive) (@avalere) header
Avalere (page inactive) (@avalere) profile picture

This page is retired. To follow the latest updates on Avalere Health, visit us at https://teapawt.org/t.co/uU4lChbHNP.

Washington, D.C
Joined August 2008
Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)Photo by Avalere (page inactive) (@avalere)
Avalere (page inactive) retweeted
Navigating uncertainty: redefining healthcare value in an evolving healthcare landscape @avalere @avalerehealth evidencebaseonline.com/navig…
3
3
124
Avalere (page inactive) retweeted
Navigating uncertainty: redefining #healthcare value in an evolving healthcare landscape @avalere @avalerehealth evidencebaseonline.com/navig…
3
3
135
Avalere (page inactive) retweeted
A new white paper from @avalere examines the future opportunities and current challenges related to adult combination vaccines in development, highlighting the need for alignment on strain selection, coverage and more. Full report: buff.ly/44SYzcA
1
2
148
Adult combo #vaccines promise streamlined protection against respiratory diseases like #flu & #COVID19 and improved uptake. But a new report from @avalere points to several barriers that must be addressed to ensure uninterrupted patient access. Learn more: bit.ly/4dqme8n
1
1
121
A new white paper from @avalere examines the future opportunities and current challenges related to adult combination vaccines in development, highlighting the need for alignment on strain selection, coverage and more. Read the full report: bit.ly/4dqme8n
1
2
144
Avalere (page inactive) retweeted
Cardiovascular therapies may require longer, larger clinical trials than other medicines and developing them is often more complex. A new @avalere whitepaper shows how the IRA's pill penalty could make development of these medicines even harder. Read more: avalere.com/insights/ira-dru…
To assess the potential implications of negotiation on the #CVD landscape, @advcardiohealth commissioned us to analyze the unique dynamics facing CVD drug development and how the #IRA may affect development decisions and timelines. Read our findings: avalere.com/insights/ira-dru…
2
5
2,416
📣 New #Medicare reform analysis from @Avalere Building on their initial research earlier this year, this new study—sponsored by PAN—spotlights the continued affordability challenges facing individuals enrolled in #MedicarePartD, despite historic reforms. panfoundation.org/new-analys…
1
1
201
We’re one week out from @STATnews’ #STATSummit! Join @KLHagan, Kelly Brantley of @Avalere, and patient advocate, George Valentine, virtually or in Boston next week. statnews.com/2023/summit/sta…
📢 Be the first to hear findings from a new analysis exploring how historic #Medicare Part D reforms could change adherence to treatment at @STATnews’ #STATSummit. Join @KLHagan, Kelly Brantley (@Avalere) and patient advocate, George Valentine, on 10/18: statnews.com/2023/summit/sta…
1
2
384
How does Washington influence access and affordability? Scott and Mark talk to Lance Grady, Executive Vice President of @avalere about how Washington’s decisions will shape the future of patient access. prescriptionforbetteraccess.…
1
121
Avalere (page inactive) retweeted
An analysis of physician payments conducted for COA by @avalere examining reimbursement trends finds that payment amounts for high-volume oncology services are generally the same or lower than they were a decade ago. ow.ly/1hxe50PTsrg
1
2
175
Avalere (page inactive) retweeted
Welcome to U.S. Business Action to End HIV @avalerehealth, @Biostaxcorp, @Mercer_US, @mtl_social, @ParamountPics, and @pfizer! We are excited to have you join and commit to accelerating progress on ending HIV. Learn more at healthaction.org/whatsnew/06…
1
1
4
255
Avalere (page inactive) retweeted
Couldn’t endorse this amazing program more! If you have an advanced degrees you’re interested in health policy/ market access, you should apply to @avalerehealth’s FDA Fellowship. I’d be glad to share about my experience. fishawackhealth.applytojob.c…
2
3
380
Today at @Asembia’s #AXS23, @KLHagan, PAN President and CEO, joined Carmine DeNardo (@Omnicell) and Kelly Brantley (@Avalere Health) for an insightful conversation on the continued need for charitable patient assistance. (1/2)
1
1
3
261
The Inflation Reduction Act is “probably the biggest change in payment policy for drugs covered by Medicare,” speakers said during Asembia’s AXS23 Summit. specialtypharmacycontinuum.c… @avalerehealth @asembiarx #AXS23 #Asembia2023 #AsembiaSummit2023 #Asembia23
1
1
155
Are you attending @asembiarx’s #AXS23? Our President and CEO, @KLHAGAN will be speaking with Kelly Brantley (@avalerehealth) and Carmine DeNardo (@Omnicell) on the continued need for patient assistance. Learn more & join us on May 3 at 8 am PT: https://teapawt.org/t.co/yjZVdaXmeY #Asembia23
1
2
320
Avalere (page inactive) retweeted
RSVP to HWS: Unpacking the Controversy over Medicare Advantage. Join moderator @larry_levitt tomorrow as he discusses a range of issues about the rapidly growing Medicare private plan option with experts @jeanniebin, @TKornfield, and Richard Kronick. kff-org.zoom.us/webinar/regi…
8
7
3,452
Avalere (page inactive) retweeted
Join me and three top notch experts -- @jeanniebin, @TKornfield, and Rick Kronick -- as we unpack the controversy over Medicare Advantage. Join the event and ask questions, or reply with things you want to know. kff-org.zoom.us/webinar/regi…
10
2
10
6,706
Avalere (page inactive) retweeted
Roses are red; Violets are blue. The #EOM may seem complex, That is why @avalerehealth is here for you! #HealthPolicyValentines
2
1
222